Englewood Lab, Inc. (KOSDAQ:950140)
8,480.00
-250.00 (-2.86%)
At close: Sep 3, 2026
Englewood Lab Revenue
Englewood Lab had revenue of 51.30B KRW in the quarter ending June 30, 2026, a decrease of -12.25%. This brings the company's revenue in the last twelve months to 218.19B, up 18.86% year-over-year. In the year 2025, Englewood Lab had annual revenue of 216.79B with 18.97% growth.
Revenue (ttm)
218.19B
Revenue Growth
+18.86%
P/S Ratio
0.78
Revenue / Employee
n/a
Employees
n/a
Market Cap
171.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 216.79B | 34.57B | 18.97% |
| Dec 31, 2024 | 182.22B | -24.56B | -11.88% |
| Dec 31, 2023 | 206.78B | 55.28B | 36.48% |
| Dec 31, 2022 | 151.51B | -9.31B | -5.79% |
| Dec 31, 2021 | 160.82B | 23.65B | 17.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CLIO Cosmetics Co.,Ltd | 329.59B |
| C&C International | 292.76B |
| Genic | 114.29B |
| Manyo Factory | 107.18B |
| Icure Pharmaceutical Incorporation | 93.45B |
| BBIA Co., Ltd. | 77.16B |
| Coreana Cosmetics | 71.65B |
| Bonne | 42.19B |
Englewood Lab News
- 24 days ago - Englewood Lab Quarterly report: Q2 2026 - Filings
- 24 days ago - Englewood Lab Slides: Q2 2026 - Filings
- 3 months ago - Englewood Lab Quarterly report: Q1 2026 - Filings
- 5 months ago - Englewood Lab Annual report: Q4 2025 - Filings
- 10 months ago - Englewood Lab Quarterly report: Q3 2025 - Filings